Brind.

A study author is based in Johns Hopkins School of Medicine, and the research is connected to Baltimore.

Steady: 0 in the last 7 days Updated sep 17

The latest in this situation

  1. A study author is based in Johns Hopkins School of Medicine, and the research is connected to Baltimore, now involving the FDA for drug approval.

How it started

2 reports, 2 independent, last reported Jul 21. The briefing below covers this first event.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

A study author is based in Johns Hopkins School of Medicine, and the research is connected to Baltimore.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. A study author is based in Johns Hopkins School of Medicine, and the research is connected to Baltimore, now involving the FDA for drug approval.Sub-event
  2. Mark Kramer, a professor at Johns Hopkins University, is involved in a study conducted with researchers from Johns Hopkins School of Medicine.Sub-event
  3. A policy relies on expert opinion regarding medical science, involving Pete Hegseth and Johns Hopkins University School of Medicine.Sub-event
  4. Hoke is confirmed to be working for the Johns Hopkins School of Medicine.1 source
  5. Study author based in Johns Hopkins School of Medicine connected to Baltimore.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped